Our Opinion

Cardiome Pharma Corporation is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.

Supporting Evidence:

Cardiome Pharma Corporation’s Vernakalant product review

“In animal models of AF and in initial clinical studies, vernakalant significantly prolonged the atrial refractory period without significantly affecting ventricular refractoriness.”

Company Description

Cardiome Pharma Corp. is a pharmaceutical company engages in provision of development and commercialization of medical products. It focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems. The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada. [Source: MarketWatch]

Company Website: http://cardiome.com